Dilution of Shareholder Value Through the Exercise of Stock Options
First written in FY2016. 13 of 22 entries say "Worsened", first in FY2020. Latest entry: 2026-07-01.
Sockets moved to the "Worse" side of this theme in 2017, 3 years before the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
18 other companies' latest entry also says "Restated".
- FY2026WorsenedAnnual report
「The maximum number of shares underlying the stock acquisition rights is 30,000 shares of the Company's common stock.」
As a subsequent event, approval was granted for the issuance of new stock acquisition rights covering up to 30,000 shares, adding potential future dilution of shareholder value. - FY2026-H1WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) ※ 30,000 (Note 1)」
The issuance of the Series 18 Stock Acquisition Rights specified 30,000 shares subject to future exercise, adding potential dilution of shareholder value from the exercise of stock options. No exercise of the rights is reported for the interim accounting period in question. - FY2025WorsenedAnnual report
「30,000 common shares of the company」
As a subsequent event, the filing reports a resolution to issue new stock acquisition rights covering 30,000 shares, adding potential future dilution of shareholder value. - FY2025-H1WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) ※ 30,000 (Note 1)」
The issuance of the Series 17 Stock Acquisition Rights specified 30,000 shares subject to future exercise, adding potential dilution from the exercise of stock options. No exercise of the rights is reported for the period in question. - FY2024WorsenedAnnual report
「30,000 common shares of the company」
As a subsequent event, the issuance of stock acquisition rights covering up to 30,000 shares was resolved, adding potential future dilution from the exercise of stock options. - FY2024-Q2WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) ※ 15,000 (Note 1)」
The issuance of the Series 16 Stock Acquisition Rights additionally specified 15,000 shares subject to future exercise, increasing the potential dilution from the exercise of stock options. - FY2023-Q2WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) ※ 11,000 (Note 1)」
The issuance of the Series 15 Stock Acquisition Rights specified 11,000 shares subject to future exercise, adding potential dilution from the exercise of stock options. - FY2022SoftenedAnnual report
「As of the date of filing this document, the number of potential shares attributable to these stock options was 157,400, equivalent to 6.4% of the 2,477,400 issued shares as of the same date.」
Potential shares decreased from 184,900, or 7.5%, in the previous fiscal year to 157,400, or 6.4%. Separately, the filing reports, as a subsequent event, approval for the issuance of new stock acquisition rights covering up to 11,000 shares. - FY2021WorsenedAnnual report
「As of the date of filing this document, the number of potential shares attributable to these stock options was 184,900, equivalent to 7.5% of the 2,477,400 issued shares as of the same date.」
Potential shares increased from 78,200, or 3.2%, in the previous fiscal year to 184,900, or 7.5%, expanding the potential for future dilution from the exercise of stock options. - FY2021-Q2WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) 107,000 (Note 1)」
The issuance of the Series 14 Stock Acquisition Rights specified 107,000 shares subject to future exercise. The potential for share dilution was quantified, but this filing does not report any actual share issuance upon exercise. - FY2020WorsenedAnnual report
「The maximum number of shares underlying the stock acquisition rights is set at 107,000 of the company's common shares.」
Existing potential shares were reported at 78,200, or 3.2% of total issued shares, while approval was subsequently granted for the issuance of new stock acquisition rights covering up to 107,000 shares, adding potential future dilution. - FY2019MaterialisedAnnual report
「The increase in issued shares represents the 8,400-share increase resulting from the exercise of stock options.」
During the fiscal year, 8,400 shares were issued upon the exercise of stock acquisition rights. As of the date of filing, potential shares totalled 78,900, or 3.2% of total issued shares. - FY2019-Q3MaterialisedAnnual report
「Note: The increase resulted from the exercise of stock acquisition rights.」
During the third-quarter accounting period, 5,000 shares were issued upon the exercise of stock acquisition rights, meaning that part of the potential dilution risk materialised as an actual share issuance. - FY2019-Q2MaterialisedAnnual report
「1 July 2018–30 September 2018 (Note) 1,200 2,472,400 503,280 401,680 (Note 1. The increase resulted from the exercise of stock acquisition rights. 2. Between 1 October 2018 and 31 October 2018, the exercise of stock acquisition rights resulted in increases of 5,000 in total issued shares and ¥2,450 thousand each in capital and capital surplus.)」
The filing states that 1,200 shares were issued upon the exercise of stock acquisition rights during the second-quarter accounting period, and a further 5,000 shares were issued in October before the filing date. Part of the potential dilution risk therefore materialised as actual share issuance. - FY2019-Q1MaterialisedAnnual report
「1 April 2018–30 June 2018 Change in total issued shares 2,200 (Note) The increase resulted from the exercise of stock acquisition rights.」
During the cumulative first-quarter period, 2,200 shares were issued upon the exercise of stock acquisition rights, meaning that part of the potential dilution risk materialised as an actual share issuance. - FY2018MaterialisedAnnual report
「The increase in issued shares represents the 8,000-share increase resulting from the exercise of stock options.」
During the fiscal year, 8,000 new shares were issued upon the exercise of stock options, meaning that part of the dilution risk materialised as an actual share issuance. As of the date of filing, potential shares totalled 98,700, or 4.0% of total issued shares. - FY2017-Q3MaterialisedAnnual report
「1,000」
The filing reports an increase of 1,000 in total issued shares during the third-quarter accounting period due to the exercise of stock acquisition rights, indicating that part of the previously potential dilution risk materialised as an actual share issuance. - FY2016First statedAnnual report
「As of the date of filing this document, the number of potential shares attributable to these stock options was 120,000, equivalent to 4.9% of the 2,458,000 issued shares as of the same date.」
The filing reports 120,000 potential shares, representing 4.9% of total issued shares, and describes the potential dilution upon exercise.